PAHC NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Phibro Animal Health Corporation · Healthcare · Drug Manufacturers - Specialty & Generic

Open interactive chart View report data
Latest close 36.33 USD
6.7% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is -15.2% below the Trend Line and sits at 31.0% of its 52-week range. The latest completed week returned 6.7%, after a 9.2% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is neither clearly cheap nor expensive. Options positioning is mixed with 27/100 conviction, while the latest news-sentiment score is 55/100. Near-term considerations: volume confirmation is below normal; earnings are due in 25d.

Setup score 33 out of 100
Latest Close 36.33 USD 31 Jul 2026
1W Return 6.7% latest completed week
4W Return 9.2% short-term follow-through
12W Return -8.8% quarterly tape
Trend Breadth 76.9% 40 of 52 weeks active
Volume Ratio 0.7x vs 13-week average
What is working
  • Price is above Fair Value, showing premium demand versus the model.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Activity pressure is negative, which weakens the current setup.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 6.7% Latest completed week; four-week move 9.2%. Indicator stack 42/36 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Mixed 27/100 conviction; expected move 12.4%. News sentiment 55/100 47 relevant articles in the latest sentiment read. Event risk 25d Next report is scheduled for 26 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -15.2% below the Trend Line and sits at 31.0% of its 52-week range. The latest completed week returned 6.7%, after a 9.2% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0612-week average 0.39

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.06Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 9.2% over four weeks, -8.8% over 12 weeks, and 40.8% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W6.7%
4W9.2%
12W-8.8%
26W-9.0%
52W40.8%
Active trend streak0 weeks
Active weeks in one year40
Trend breadth76.9%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.87Latest activity-pressure read.
Pressure change24.8%Four-week change in activity pressure.
Leadership-19.36Latest relative-leadership reading.
RS change33.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 100% Model confidence 96%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength68/100Blend of value, momentum, and quality. Underlying universe rank 33; rank 1 is best.
Value69/100Relative valuation strength. Underlying universe rank 32; rank 1 is best.
Quality29/100Profitability and accounting quality. Underlying universe rank 72; rank 1 is best.
Momentum66/100Medium-term price momentum. Underlying universe rank 35; rank 1 is best.
Growth95/100Revenue and earnings growth. Underlying universe rank 6; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework64/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
14.5x
Price divided by trailing earnings.
Price / sales
0.9x
Market value relative to trailing revenue.
EV / EBITDA
9.4x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
5.7%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
32.5%
Gross profit retained from each unit of revenue.
Operating margin
11.6%
Operating profit retained from revenue.
Free-cash-flow margin
8.0%
Free cash flow generated from revenue.
Return on invested capital
11.8%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
26.0%
Latest one-year revenue growth.
EPS growth
199.6%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-4.8%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
1.4%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
1.4%
Dividend yield plus net buyback yield.
Net debt / EBITDA
3.3x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningMixed

PAHC shows mixed options pressure with a 27/100 conviction score, put-call volume ratio of n/a, expected move of 12.4%, and Sharemaestro trend signal inactive.

Conviction27/100
Expected move12.4%
Put/call volume
Pressure-8
Speculation0
Volatility75
Trend agreement61
Open options detail
Insider activity2 / 18

2 acquisitions and 18 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment55/100

Weighted news tone is neutral across 47 relevant articles.

18 positive · 26 neutral · 3 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings25dNext report is scheduled for 26 Aug 2026; event risk rises as the date approaches.
Options expected move12.4%Nearest-chain priced movement where available.
52-week drawdown-39.3%Distance below the 52-week high.
13-week volatility9.0%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+32.2%Week of 6 Feb.
Worst week-27.1%Week of 8 May.
Latest week+6.7%Week of 31 Jul.

Shape of recent returns

Strong gains6
Modest gains8
Flat weeks0
Modest losses8
Sharp losses4
Recent vol9.0%13-week weekly-return volatility.
Base vol7.9%52-week weekly-return volatility.
Up/down split31/21Count of positive and negative weeks in the 52-week window.
Average skew5.4% / -5.5%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape30/100

Trend, activity pressure, participation, and risk combine to a 30/100 tape read.

 Indicator analysis9/100

Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.

Activity pressure 0.06; No reversal markers Factors57/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Cornerstone Growth rank 47; Buyback Yield rank 59; Small Cap Core rank 63 SVQF64/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 263.0 of 726 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options47/100

PAHC shows mixed options pressure with a 27/100 conviction score, put-call volume ratio of n/a, expected move of 12.4%, and Sharemaestro trend signal inactive.

Mixed · Options-market disagreement · Expected move 12.4% Sentiment55/100

Weighted news tone is neutral across 47 relevant articles.

Millennium group (NASDAQ: PAHC) discloses 1.06M-share Phibro Animal Health position Insiders2 / 18

2 acquisitions and 18 disposals in the latest 180-day insider tape.

 Earnings25d

Next report is scheduled for 26 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202636.33 USD6.7%42.84 USD25.39 USD-0.87-19.361.2MOff
24 Jul 202634.03 USD2.2%42.87 USD25.24 USD-0.99-23.90852.2KOff
17 Jul 202633.31 USD3.9%43.00 USD25.11 USD-1.02-26.741.6MOff
10 Jul 202632.07 USD-3.6%43.12 USD24.99 USD-1.10-32.481.5MOff
3 Jul 202633.26 USD5.0%43.38 USD24.87 USD-1.15-28.941.4MOff
26 Jun 202631.69 USD-0.5%43.57 USD24.74 USD-1.12-31.771.3MOff
19 Jun 202631.85 USD1.0%43.90 USD24.62 USD-1.17-34.541.1MOff
12 Jun 202631.53 USD-2.8%44.22 USD24.50 USD-1.16-33.511.3MOff
5 Jun 202632.43 USD5.7%44.66 USD24.38 USD-1.09-30.062.4MOff
29 May 202630.67 USD-7.4%45.02 USD24.25 USD-1.07-36.811.4MOff
22 May 202633.13 USD-3.2%45.39 USD24.13 USD-0.56-29.861.8MOff
15 May 202634.24 USD-14.1%45.68 USD24.00 USD-0.18-26.622.9MOff
8 May 202639.85 USD-27.1%45.85 USD23.86 USD0.30-14.803.3MOn
1 May 202654.68 USD-0.5%45.73 USD23.69 USD0.7623.731.6MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.